Skip to main content
Premium Trial:

Request an Annual Quote

Xeotron Demonstrates New Peptide Microarray Technique

NEW YORK, July 31-Xeotron has developed a new way to make peptide microchips using digital photolithography, the company said.


Using a silicon-based microfluidics chip and a photoreactive process, Xeotron researchers were able to generate between 2,000 and 4,000 peptide sequences on a 1.5-square-cm chip.


Company researchers verified that the microchip sequences showed specific antibody binding, suggesting that the technique could prove useful in developing commercially or clinically useful peptide chips.


According to the authors, this method is significantly cheaper and more efficient than the photomasking approach used by other peptide chip developers.


The technique, the result of a collaboration with scientists at the University of Houston and the University of Michigan, appears in a journal article in the July 22 edition of Nature Biotechnology.


Xeotron is a privately held photochemical and microfluidics company based in Houston.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.